Earlier today, we held an emergency Private Dealroom meeting.
We did the whole thing remotely – I’m still on lockdown here in California, after all.
Normally, I don’t like doing our most sensitive Dealroom meetings without getting everyone together in person. And most of the time, we have the flexibility to schedule around making that happen.
But this time was different – because the deal we analyzed today is only accepting investors for 15 more days. After that, the window of opportunity will be closed… maybe forever.
It’s also one of the most impressive startups I’ve seen in a long time. It may be one of the most interesting, exciting, and promising companies we’ve ever seen.
For starters, this company checks all my boxes. It’s addressing a huge market; right now, it stands at an impressive $19 billion, and it’s projected to grow to $26 billion in just a few years.
Another thing I liked about it is the space it operates in. See, the tech that this medical device startup has developed is both unique and proprietary… which means nobody else can swoop in and steal it. But looking through some old records reveals that similar companies have had some stunning exits in the past decade. Sounds like a pretty favorable market to me.
As you know, one of the most important things I look for in a company is that it solves a problem. The more urgent the problem, the better.
Well, get a load of this: the company we discussed today could change the lives of hundreds of thousands of Americans a year. That’s because this startup’s tech aims to dramatically increase the success rate of surgical procedures that are becoming more common every single year: knee and hip replacements.
These procedures are performed 600,000 times annually in the U.S. alone. You probably know at least one person who’s had one. And if you do, you know that these surgeries often leave patients with lifelong pain and discomfort. Every year, tens of thousands of them fail altogether.
The new tech in question combines 3D printing with state-of-the-art robotics to make and insert bespoke implants in a way that’s never been done before.
And then there’s my favorite part: the founding team.
This startup was founded by a world-renowned orthopedic surgeon with 17 years of experience under his belt. He’s literally performed thousands of joint replacement surgeries himself – which means he eats, sleeps, and breathes his work.
He’s got a really fascinating story behind his work… which is why we teleconferenced him into the Dealroom today. We honestly just couldn’t wait to hear what he had to say about what looked like an incredible opportunity – and once we heard from Dr. Doug, we knew we were looking at a startup with very real unicorn potential.
You really won’t get the full experience hearing it from me. You need to hear from the doctor himself… and I suggest you do it fast.
Because two weeks from tomorrow, the opportunity to invest in this startup for this round will be over, full stop.
Even if you aren’t looking to make any angel investments right now, you should hear what this guy has to say. It’s completely fascinating – and it’s a rare opportunity to hear from such an esteemed industry expert.
Just click here to check it out.
Until next time,